Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.
Address
1065 EAST HILLSDALE BLVD., SUITE 100
FOSTER CITY, CA 94404
Founded
2017
Number of Employees
66
Website
http://www.ternspharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)